Article

South China Morning PostSouth China Morning Post on 2020-04-11 13:59

Experimental coronavirus treatment remdesivir shows promise in study where two thirds of patients improved

Study sponsored by drug’s developer Gilead finds dozens of patients, including some on ventilators, improved after 10 days of treatment.

Related news